Sign in

CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(919) 636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,310,718
in 4 filings, $1.2M under 10b5-1 plans

Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-31 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +1,042 130,507
2025-01-06 Raykov Rosty Director Sale 10b5-1 −2,431 $6.08 $15K 91,432
2025-01-06 Raykov Rosty Director Sale 10b5-1 −7,569 $6.08 $46K 83,863
2024-12-31 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +1,042 129,465
2024-12-31 Raykov Rosty Director Grant or award +2,431 93,863
2024-12-20 Raykov Rosty Director Option exercise +25,000 $2.69 $67K 91,432
2024-12-20 Raykov Rosty Director Option exercise · Stock Options −25,000 $2.69 $67K 1,675,000
2024-12-05 Raykov Rosty Director Sale 10b5-1 −796 $6.04 $5K 66,432
2024-12-03 Raykov Rosty Director Sale 10b5-1 −1,635 $6.13 $10K 67,228
2024-12-02 Raykov Rosty Director Grant or award 10b5-1 +2,431 68,863
2024-12-02 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +1,042 128,423
2024-12-02 RALLIS CHRIS A Director Option exercise 10b5-1 +10,000 $2.69 $27K 58,623
2024-12-02 RALLIS CHRIS A Director Sale 10b5-1 −6,409 $6.14 $39K 52,214
2024-12-02 RALLIS CHRIS A Director Option exercise · Common Shares 10b5-1 −10,000 $2.69 $27K 184,698
2024-11-18 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise +15,816 $2.45 $39K 127,381
2024-11-18 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise · Stock Options −15,816 $2.45 $39K 689,184
2024-11-13 Cioffi Christiana Marie Chief Strategy Officer Grant or award · Stock Options +150,000 $4.23 $635K 150,000
2024-11-13 Evans Terry L Chief Commercial Officer Grant or award · Stock Options +150,000 $4.23 $635K 150,000
2024-11-13 Sayad Pierre Sargis Chief Medical Officer Grant or award · Stock Options +150,000 $4.23 $635K 150,000
2024-11-04 Raykov Rosty Director Sale 10b5-1 −2,431 $4.31 $10K 66,432

Page 11 of 17 · 340 trades